The Society for Immunotherapy of Cancer (SITC) hosted "Session 300: Genetically Modified Cell Therapy" during the SITC 2017 Annual Meeting on November 12, 2017. Available here are the presentation slides and video from the session.Program Organizers
Program SummaryThe Society for Immunotherapy of Cancer's (SITC) 32nd Annual Meeting provided a multidisciplinary educational and interactive environment focused on improving outcomes for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy.
Meeting: SITC 32 Annual Meeting; Session 300: Genetically Modified Cell Thearpy; Presenter: Stephen Gottschalk, MD – St. Jude Children's Research Hospital; Date: November 12, 201700:25:17
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com